Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Paclitaxel Injection Market 2018, Forecast to 2023

Publisher Name :
Date: 13-Jun-2018
No. of pages: 133

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.

Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.

Scope of the Report:

This report focuses on the Paclitaxel Injection in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

In recent years, the growing population and increasing disease incidence of ovarian cancer, breast cancer and other cancers drive the global paclitaxel injection industry developing.

In the past five years from 2010-2014, global paclitaxel injection industry developed fast with a larger than 15% annual production growth rate. In China, due to the late start, the production growth rate is 12%~17%, which is a little lower than global average.

In the next few years, with the growing attention on women cancers from the whole society and much larger investment on R&D of paclitaxel injection, this industry will continue developing at a high speed. What's more, because of the high gross profit of producing and selling paclitaxel injection, more and more investors will enter into this industry.

At present, the production of paclitaxel injection mainly concentrated in US, China and EU, the three regions produced about 77.30% of the global total products. Of those, US are the largest production region with a 42.69% of global production market share.

In the future, with the expanded capacity of paclitaxel injection, the manufacturers will face the high risk of price and gross margin decline.

The worldwide market for Paclitaxel Injection is expected to grow at a CAGR of roughly 11.0% over the next five years, will reach 3680 million US$ in 2023, from 2180 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Bristol-Myers Squibb

- Celgene Corporation

- Hospira

- Biological E.

- Taj Accura

- Khandelwal Laboratories

- Luye Pharma

- Beijing Youcare

- Beijing Union

- Haiyao

- Chuntch

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Drug Strength

- Raw meterial Paclitaxel API source

Market Segment by Applications, can be divided into

- Ovarian cancer

- Breast cancer

- Cervical cancer

- Pancreatic cancer

- Other

There are 15 Chapters to deeply display the global Paclitaxel Injection market.

Chapter 1, to describe Paclitaxel Injection Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Paclitaxel Injection, with sales, revenue, and price of Paclitaxel Injection, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Paclitaxel Injection, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Paclitaxel Injection market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Paclitaxel Injection sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Paclitaxel Injection Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Paclitaxel Injection Introduction
1.2 Market Analysis by Type
1.2.1 Drug Strength
1.2.2 Raw meterial Paclitaxel API source
1.3 Market Analysis by Applications
1.3.1 Ovarian cancer
1.3.2 Breast cancer
1.3.3 Cervical cancer
1.3.4 Pancreatic cancer
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Business Overview
2.1.1.1 Bristol-Myers Squibb Description
2.1.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview
2.1.2 Bristol-Myers Squibb Paclitaxel Injection Product Introduction
2.1.2.1 Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
2.1.2.2 Paclitaxel Injection Product Information
2.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Bristol-Myers Squibb Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Bristol-Myers Squibb Paclitaxel Injection Market Share in 2017
2.2 Celgene Corporation
2.2.1 Business Overview
2.2.1.1 Celgene Corporation Description
2.2.1.2 Celgene Corporation Headquarter, Main Business and Finance Overview
2.2.2 Celgene Corporation Paclitaxel Injection Product Introduction
2.2.2.1 Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
2.2.2.2 Paclitaxel Injection Product Information
2.2.3 Celgene Corporation Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Celgene Corporation Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Celgene Corporation Paclitaxel Injection Market Share in 2017
2.3 Hospira
2.3.1 Business Overview
2.3.1.1 Hospira Description
2.3.1.2 Hospira Headquarter, Main Business and Finance Overview
2.3.2 Hospira Paclitaxel Injection Product Introduction
2.3.2.1 Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
2.3.2.2 Paclitaxel Injection Product Information
2.3.3 Hospira Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Hospira Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Hospira Paclitaxel Injection Market Share in 2017
2.4 Biological E.
2.4.1 Business Overview
2.4.1.1 Biological E. Description
2.4.1.2 Biological E. Headquarter, Main Business and Finance Overview
2.4.2 Biological E. Paclitaxel Injection Product Introduction
2.4.2.1 Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
2.4.2.2 Paclitaxel Injection Product Information
2.4.3 Biological E. Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Biological E. Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Biological E. Paclitaxel Injection Market Share in 2017
2.5 Taj Accura
2.5.1 Business Overview
2.5.1.1 Taj Accura Description
2.5.1.2 Taj Accura Headquarter, Main Business and Finance Overview
2.5.2 Taj Accura Paclitaxel Injection Product Introduction
2.5.2.1 Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
2.5.2.2 Paclitaxel Injection Product Information
2.5.3 Taj Accura Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Taj Accura Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Taj Accura Paclitaxel Injection Market Share in 2017
2.6 Khandelwal Laboratories
2.6.1 Business Overview
2.6.1.1 Khandelwal Laboratories Description
2.6.1.2 Khandelwal Laboratories Headquarter, Main Business and Finance Overview
2.6.2 Khandelwal Laboratories Paclitaxel Injection Product Introduction
2.6.2.1 Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
2.6.2.2 Paclitaxel Injection Product Information
2.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Khandelwal Laboratories Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Khandelwal Laboratories Paclitaxel Injection Market Share in 2017
2.7 Luye Pharma
2.7.1 Business Overview
2.7.1.1 Luye Pharma Description
2.7.1.2 Luye Pharma Headquarter, Main Business and Finance Overview
2.7.2 Luye Pharma Paclitaxel Injection Product Introduction
2.7.2.1 Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
2.7.2.2 Paclitaxel Injection Product Information
2.7.3 Luye Pharma Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Luye Pharma Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Luye Pharma Paclitaxel Injection Market Share in 2017
2.8 Beijing Youcare
2.8.1 Business Overview
2.8.1.1 Beijing Youcare Description
2.8.1.2 Beijing Youcare Headquarter, Main Business and Finance Overview
2.8.2 Beijing Youcare Paclitaxel Injection Product Introduction
2.8.2.1 Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
2.8.2.2 Paclitaxel Injection Product Information
2.8.3 Beijing Youcare Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Beijing Youcare Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Beijing Youcare Paclitaxel Injection Market Share in 2017
2.9 Beijing Union
2.9.1 Business Overview
2.9.1.1 Beijing Union Description
2.9.1.2 Beijing Union Headquarter, Main Business and Finance Overview
2.9.2 Beijing Union Paclitaxel Injection Product Introduction
2.9.2.1 Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
2.9.2.2 Paclitaxel Injection Product Information
2.9.3 Beijing Union Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Beijing Union Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Beijing Union Paclitaxel Injection Market Share in 2017
2.10 Haiyao
2.10.1 Business Overview
2.10.1.1 Haiyao Description
2.10.1.2 Haiyao Headquarter, Main Business and Finance Overview
2.10.2 Haiyao Paclitaxel Injection Product Introduction
2.10.2.1 Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
2.10.2.2 Paclitaxel Injection Product Information
2.10.3 Haiyao Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Haiyao Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Haiyao Paclitaxel Injection Market Share in 2017
2.11 Chuntch
2.11.1 Business Overview
2.11.2 Chuntch Paclitaxel Injection Product Introduction
2.11.3 Chuntch Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Paclitaxel Injection Market Competition, by Manufacturer
3.1 Global Paclitaxel Injection Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Paclitaxel Injection Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Paclitaxel Injection Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Paclitaxel Injection Manufacturer Market Share in 2017
3.4.2 Top 5 Paclitaxel Injection Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Paclitaxel Injection Market Analysis by Regions
4.1 Global Paclitaxel Injection Sales, Revenue and Market Share by Regions
4.1.1 Global Paclitaxel Injection Sales by Regions (2013-2018)
4.1.2 Global Paclitaxel Injection Revenue by Regions (2013-2018)
4.2 North America Paclitaxel Injection Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Paclitaxel Injection Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Paclitaxel Injection Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Paclitaxel Injection Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Paclitaxel Injection Sales, Revenue and Growth Rate (2013-2018)
5 North America Paclitaxel Injection by Countries, Type, Application and Manufacturers
5.1 North America Paclitaxel Injection Sales, Revenue and Market Share by Countries
5.1.1 North America Paclitaxel Injection Sales by Countries (2013-2018)
5.1.2 North America Paclitaxel Injection Revenue by Countries (2013-2018)
5.1.3 United States Paclitaxel Injection Sales and Growth Rate (2013-2018)
5.1.4 Canada Paclitaxel Injection Sales and Growth Rate (2013-2018)
5.1.5 Mexico Paclitaxel Injection Sales and Growth Rate (2013-2018)
5.2 North America Paclitaxel Injection Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Paclitaxel Injection Sales by Manufacturers (2016-2017)
5.2.2 North America Paclitaxel Injection Revenue by Manufacturers (2016-2017)
5.3 North America Paclitaxel Injection Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Paclitaxel Injection Sales and Sales Share by Type (2013-2018)
5.3.2 North America Paclitaxel Injection Revenue and Revenue Share by Type (2013-2018)
5.4 North America Paclitaxel Injection Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Paclitaxel Injection Sales and Sales Share by Application (2013-2018)
5.4.2 North America Paclitaxel Injection Revenue and Revenue Share by Application (2013-2018)
6 Europe Paclitaxel Injection by Countries, Type, Application and Manufacturers
6.1 Europe Paclitaxel Injection Sales, Revenue and Market Share by Countries
6.1.1 Europe Paclitaxel Injection Sales by Countries (2013-2018)
6.1.2 Europe Paclitaxel Injection Revenue by Countries (2013-2018)
6.1.3 Germany Paclitaxel Injection Sales and Growth Rate (2013-2018)
6.1.4 UK Paclitaxel Injection Sales and Growth Rate (2013-2018)
6.1.5 France Paclitaxel Injection Sales and Growth Rate (2013-2018)
6.1.6 Russia Paclitaxel Injection Sales and Growth Rate (2013-2018)
6.1.7 Italy Paclitaxel Injection Sales and Growth Rate (2013-2018)
6.2 Europe Paclitaxel Injection Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Paclitaxel Injection Sales by Manufacturers (2016-2017)
6.2.2 Europe Paclitaxel Injection Revenue by Manufacturers (2016-2017)
6.3 Europe Paclitaxel Injection Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Paclitaxel Injection Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Paclitaxel Injection Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Paclitaxel Injection Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Paclitaxel Injection Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Paclitaxel Injection Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Paclitaxel Injection by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Paclitaxel Injection Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Paclitaxel Injection Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Paclitaxel Injection Revenue by Countries (2013-2018)
7.1.3 China Paclitaxel Injection Sales and Growth Rate (2013-2018)
7.1.4 Japan Paclitaxel Injection Sales and Growth Rate (2013-2018)
7.1.5 Korea Paclitaxel Injection Sales and Growth Rate (2013-2018)
7.1.6 India Paclitaxel Injection Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Paclitaxel Injection Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Paclitaxel Injection Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Paclitaxel Injection Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Paclitaxel Injection Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Paclitaxel Injection Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Paclitaxel Injection Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Paclitaxel Injection Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Paclitaxel Injection Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Paclitaxel Injection Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Paclitaxel Injection Revenue and Revenue Share by Application (2013-2018)
8 South America Paclitaxel Injection by Countries, Type, Application and Manufacturers
8.1 South America Paclitaxel Injection Sales, Revenue and Market Share by Countries
8.1.1 South America Paclitaxel Injection Sales by Countries (2013-2018)
8.1.2 South America Paclitaxel Injection Revenue by Countries (2013-2018)
8.1.3 Brazil Paclitaxel Injection Sales and Growth Rate (2013-2018)
8.1.4 Argentina Paclitaxel Injection Sales and Growth Rate (2013-2018)
8.1.5 Colombia Paclitaxel Injection Sales and Growth Rate (2013-2018)
8.2 South America Paclitaxel Injection Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Paclitaxel Injection Sales by Manufacturers (2016-2017)
8.2.2 South America Paclitaxel Injection Revenue by Manufacturers (2016-2017)
8.3 South America Paclitaxel Injection Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Paclitaxel Injection Sales and Sales Share by Type (2013-2018)
8.3.2 South America Paclitaxel Injection Revenue and Revenue Share by Type (2013-2018)
8.4 South America Paclitaxel Injection Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Paclitaxel Injection Sales and Sales Share by Application (2013-2018)
8.4.2 South America Paclitaxel Injection Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Paclitaxel Injection by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Paclitaxel Injection Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Paclitaxel Injection Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Paclitaxel Injection Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Paclitaxel Injection Sales and Growth Rate (2013-2018)
9.1.4 UAE Paclitaxel Injection Sales and Growth Rate (2013-2018)
9.1.5 Egypt Paclitaxel Injection Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Paclitaxel Injection Sales and Growth Rate (2013-2018)
9.1.7 South Africa Paclitaxel Injection Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Paclitaxel Injection Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Paclitaxel Injection Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Paclitaxel Injection Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Paclitaxel Injection Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Paclitaxel Injection Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Paclitaxel Injection Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Paclitaxel Injection Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Paclitaxel Injection Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Paclitaxel Injection Revenue and Revenue Share by Application (2013-2018)
10 Global Paclitaxel Injection Market Segment by Type
10.1 Global Paclitaxel Injection Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Paclitaxel Injection Sales and Market Share by Type (2013-2018)
10.1.2 Global Paclitaxel Injection Revenue and Market Share by Type (2013-2018)
10.2 Drug Strength Sales Growth and Price
10.2.1 Global Drug Strength Sales Growth (2013-2018)
10.2.2 Global Drug Strength Price (2013-2018)
10.3 Raw meterial Paclitaxel API source Sales Growth and Price
10.3.1 Global Raw meterial Paclitaxel API source Sales Growth (2013-2018)
10.3.2 Global Raw meterial Paclitaxel API source Price (2013-2018)
11 Global Paclitaxel Injection Market Segment by Application
11.1 Global Paclitaxel Injection Sales Market Share by Application (2013-2018)
11.2 Ovarian cancer Sales Growth (2013-2018)
11.3 Breast cancer Sales Growth (2013-2018)
11.4 Cervical cancer Sales Growth (2013-2018)
11.5 Pancreatic cancer Sales Growth (2013-2018)
11.6 Other Sales Growth (2013-2018)
12 Paclitaxel Injection Market Forecast (2018-2023)
12.1 Global Paclitaxel Injection Sales, Revenue and Growth Rate (2018-2023)
12.2 Paclitaxel Injection Market Forecast by Regions (2018-2023)
12.2.1 North America Paclitaxel Injection Market Forecast (2018-2023)
12.2.2 Europe Paclitaxel Injection Market Forecast (2018-2023)
12.2.3 Asia-Pacific Paclitaxel Injection Market Forecast (2018-2023)
12.2.4 South America Paclitaxel Injection Market Forecast (2018-2023)
12.2.5 Middle East and Africa Paclitaxel Injection Market Forecast (2018-2023)
12.3 Paclitaxel Injection Market Forecast by Type (2018-2023)
12.3.1 Global Paclitaxel Injection Sales Forecast by Type (2018-2023)
12.3.2 Global Paclitaxel Injection Market Share Forecast by Type (2018-2023)
12.4 Paclitaxel Injection Market Forecast by Application (2018-2023)
12.4.1 Global Paclitaxel Injection Sales Forecast by Application (2018-2023)
12.4.2 Global Paclitaxel Injection Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Paclitaxel Injection Picture
Table Product Specifications of Paclitaxel Injection
Figure Global Paclitaxel Injection CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Paclitaxel Injection CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Paclitaxel Injection by Types in 2017
Figure Drug Strength Picture
Table Major Manufacturers of Drug Strength
Figure Raw meterial Paclitaxel API source Picture
Table Major Manufacturers of Raw meterial Paclitaxel API source
Figure Paclitaxel Injection Sales Market Share by Applications in 2017
Figure Ovarian cancer Picture
Figure Breast cancer Picture
Figure Cervical cancer Picture
Figure Pancreatic cancer Picture
Figure Other Picture
Figure United States Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure France Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure UK Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure China Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure India Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Paclitaxel Injection Revenue (Value) and Growth Rate (2013-2023)
Table Bristol-Myers Squibb Headquarter, Established, Main Business and Finance Overview (2017)
Table Bristol-Myers Squibb Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
Table Bristol-Myers Squibb Paclitaxel Injection Product
Table Bristol-Myers Squibb Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bristol-Myers Squibb Paclitaxel Injection Sales Market Share in 2017
Figure Global Bristol-Myers Squibb Paclitaxel Injection Revenue Market Share in 2017
Table Celgene Corporation Headquarter, Established, Main Business and Finance Overview (2017)
Table Celgene Corporation Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
Table Celgene Corporation Paclitaxel Injection Product
Table Celgene Corporation Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Celgene Corporation Paclitaxel Injection Sales Market Share in 2017
Figure Global Celgene Corporation Paclitaxel Injection Revenue Market Share in 2017
Table Hospira Headquarter, Established, Main Business and Finance Overview (2017)
Table Hospira Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
Table Hospira Paclitaxel Injection Product
Table Hospira Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Hospira Paclitaxel Injection Sales Market Share in 2017
Figure Global Hospira Paclitaxel Injection Revenue Market Share in 2017
Table Biological E. Headquarter, Established, Main Business and Finance Overview (2017)
Table Biological E. Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
Table Biological E. Paclitaxel Injection Product
Table Biological E. Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Biological E. Paclitaxel Injection Sales Market Share in 2017
Figure Global Biological E. Paclitaxel Injection Revenue Market Share in 2017
Table Taj Accura Headquarter, Established, Main Business and Finance Overview (2017)
Table Taj Accura Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
Table Taj Accura Paclitaxel Injection Product
Table Taj Accura Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Taj Accura Paclitaxel Injection Sales Market Share in 2017
Figure Global Taj Accura Paclitaxel Injection Revenue Market Share in 2017
Table Khandelwal Laboratories Headquarter, Established, Main Business and Finance Overview (2017)
Table Khandelwal Laboratories Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
Table Khandelwal Laboratories Paclitaxel Injection Product
Table Khandelwal Laboratories Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Khandelwal Laboratories Paclitaxel Injection Sales Market Share in 2017
Figure Global Khandelwal Laboratories Paclitaxel Injection Revenue Market Share in 2017
Table Luye Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table Luye Pharma Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
Table Luye Pharma Paclitaxel Injection Product
Table Luye Pharma Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Luye Pharma Paclitaxel Injection Sales Market Share in 2017
Figure Global Luye Pharma Paclitaxel Injection Revenue Market Share in 2017
Table Beijing Youcare Headquarter, Established, Main Business and Finance Overview (2017)
Table Beijing Youcare Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
Table Beijing Youcare Paclitaxel Injection Product
Table Beijing Youcare Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Beijing Youcare Paclitaxel Injection Sales Market Share in 2017
Figure Global Beijing Youcare Paclitaxel Injection Revenue Market Share in 2017
Table Beijing Union Headquarter, Established, Main Business and Finance Overview (2017)
Table Beijing Union Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
Table Beijing Union Paclitaxel Injection Product
Table Beijing Union Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Beijing Union Paclitaxel Injection Sales Market Share in 2017
Figure Global Beijing Union Paclitaxel Injection Revenue Market Share in 2017
Table Haiyao Headquarter, Established, Main Business and Finance Overview (2017)
Table Haiyao Paclitaxel Injection Production Bases, Sales Regions and Major Competitors
Table Haiyao Paclitaxel Injection Product
Table Haiyao Paclitaxel Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Haiyao Paclitaxel Injection Sales Market Share in 2017
Figure Global Haiyao Paclitaxel Injection Revenue Market Share in 2017
Table Chuntch
Table Chuntch Paclitaxel Injection
Table Global Paclitaxel Injection Sales by Manufacturer (2016-2017)
Figure Global Paclitaxel Injection Sales Market Share by Manufacturer in 2016
Figure Global Paclitaxel Injection Sales Market Share by Manufacturer in 2017
Table Global Paclitaxel Injection Revenue by Manufacturer (2016-2017)
Figure Global Paclitaxel Injection Revenue Market Share by Manufacturer in 2016
Figure Global Paclitaxel Injection Revenue Market Share by Manufacturer in 2017
Table Global Paclitaxel Injection Price by Manufacturer (2016-2017)
Figure Top 3 Paclitaxel Injection Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Paclitaxel Injection Manufacturer (Revenue) Market Share in 2017
Figure Global Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure Global Paclitaxel Injection Revenue and Growth Rate (2013-2018)
Table Global Paclitaxel Injection Sales by Regions (2013-2018)
Table Global Paclitaxel Injection Sales Market Share by Regions (2013-2018)
Table Global Paclitaxel Injection Revenue by Regions (2013-2018)
Figure Global Paclitaxel Injection Revenue Market Share by Regions in 2013
Figure Global Paclitaxel Injection Revenue Market Share by Regions in 2017
Figure North America Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure North America Paclitaxel Injection Revenue and Growth Rate (2013-2018)
Figure Europe Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure Europe Paclitaxel Injection Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Paclitaxel Injection Revenue and Growth Rate (2013-2018)
Figure South America Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure South America Paclitaxel Injection Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Paclitaxel Injection Revenue and Growth Rate (2013-2018)
Figure North America Paclitaxel Injection Revenue and Growth Rate (2013-2018)
Table North America Paclitaxel Injection Sales by Countries (2013-2018)
Table North America Paclitaxel Injection Sales Market Share by Countries (2013-2018)
Figure North America Paclitaxel Injection Sales Market Share by Countries in 2013
Figure North America Paclitaxel Injection Sales Market Share by Countries in 2017
Table North America Paclitaxel Injection Revenue by Countries (2013-2018)
Table North America Paclitaxel Injection Revenue Market Share by Countries (2013-2018)
Figure North America Paclitaxel Injection Revenue Market Share by Countries in 2013
Figure North America Paclitaxel Injection Revenue Market Share by Countries in 2017
Figure United States Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure Canada Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure Mexico Paclitaxel Injection Sales and Growth Rate (2013-2018)
Table North America Paclitaxel Injection Sales by Manufacturer (2016-2017)
Figure North America Paclitaxel Injection Sales Market Share by Manufacturer in 2016
Figure North America Paclitaxel Injection Sales Market Share by Manufacturer in 2017
Table North America Paclitaxel Injection Revenue by Manufacturer (2016-2017)
Figure North America Paclitaxel Injection Revenue Market Share by Manufacturer in 2016
Figure North America Paclitaxel Injection Revenue Market Share by Manufacturer in 2017
Table North America Paclitaxel Injection Sales by Type (2013-2018)
Table North America Paclitaxel Injection Sales Share by Type (2013-2018)
Table North America Paclitaxel Injection Revenue by Type (2013-2018)
Table North America Paclitaxel Injection Revenue Share by Type (2013-2018)
Table North America Paclitaxel Injection Sales by Application (2013-2018)
Table North America Paclitaxel Injection Sales Share by Application (2013-2018)
Table North America Paclitaxel Injection Revenue by Application (2013-2018)
Table North America Paclitaxel Injection Revenue Share by Application (2013-2018)
Figure Europe Paclitaxel Injection Revenue and Growth Rate (2013-2018)
Table Europe Paclitaxel Injection Sales by Countries (2013-2018)
Table Europe Paclitaxel Injection Sales Market Share by Countries (2013-2018)
Table Europe Paclitaxel Injection Revenue by Countries (2013-2018)
Figure Europe Paclitaxel Injection Revenue Market Share by Countries in 2016
Figure Europe Paclitaxel Injection Revenue Market Share by Countries in 2017
Figure Germany Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure UK Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure France Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure Russia Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure Italy Paclitaxel Injection Sales and Growth Rate (2013-2018)
Table Europe Paclitaxel Injection Sales by Manufacturer (2016-2017)
Figure Europe Paclitaxel Injection Sales Market Share by Manufacturer in 2016
Figure Europe Paclitaxel Injection Sales Market Share by Manufacturer in 2017
Table Europe Paclitaxel Injection Revenue by Manufacturer (2016-2017)
Figure Europe Paclitaxel Injection Revenue Market Share by Manufacturer in 2016
Figure Europe Paclitaxel Injection Revenue Market Share by Manufacturer in 2017
Table Europe Paclitaxel Injection Sales by Type (2013-2018)
Table Europe Paclitaxel Injection Sales Share by Type (2013-2018)
Table Europe Paclitaxel Injection Revenue by Type (2013-2018)
Table Europe Paclitaxel Injection Revenue Share by Type (2013-2018)
Table Europe Paclitaxel Injection Sales by Application (2013-2018)
Table Europe Paclitaxel Injection Sales Share by Application (2013-2018)
Table Europe Paclitaxel Injection Revenue by Application (2013-2018)
Table Europe Paclitaxel Injection Revenue Share by Application (2013-2018)
Figure Asia-Pacific Paclitaxel Injection Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Paclitaxel Injection Sales by Countries (2013-2018)
Table Asia-Pacific Paclitaxel Injection Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Paclitaxel Injection Sales Market Share by Countries 2017
Table Asia-Pacific Paclitaxel Injection Revenue by Countries (2013-2018)
Figure Asia-Pacific Paclitaxel Injection Revenue Market Share by Countries 2017
Figure China Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure Japan Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure Korea Paclitaxel Injection Sales and Growth Rate (2013-2018)
Figure India Paclitaxel Injection Sales and Growth Rate (201
  • Global Capecitabine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 134
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Capecitabine Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 135
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • 2018-2023 Global Cancer Treatment Drugs Consumption Market Report
    Published: 10-Aug-2018        Price: US 4660 Onwards        Pages: 179
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Cancer Treatment Drugs market for 2018-2023. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. The classification of cancer treatment drugs includes chemotherapy, targeted th......
  • Global Hydroxycarbamide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Aug-2018        Price: US 3480 Onwards        Pages: 137
    Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Hydroxycarbamide Market 2018, Forecast to 2023
    Published: 10-Aug-2018        Price: US 4880 Onwards        Pages: 130
    Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the......
  • China Cancer Drugs Market, by Drugs (Cytotoxic, Targeted, etc.), Cancer Types(Lung, Stomach, Breast, etc.), by Therapy & Companies
    Published: 10-Aug-2018        Price: US 1990 Onwards        Pages: 102
    Anti-Cancer drugs are the drugs which are used to reduce or prevent the cell proliferation of cancerous tissues. China Cancer Drugs Market is projected to reach US$ 30 Billion by the year 2024; owing to the increasing prevalence of various types of cancer, changing lifestyle & dietary habits, growing aging population, rising demand of targeted drug therapy and the patent expiration of key cancer drugs. Cancer is one of the leading causes of death worldwide and is a major public health bur......
  • Global Cancer Treatment Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 07-Aug-2018        Price: US 3480 Onwards        Pages: 147
    Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Scope of the Report: This report focuses on the Cancer Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Cancer Treatment Drugs Market 2018, Forecast to 2023
    Published: 07-Aug-2018        Price: US 4880 Onwards        Pages: 153
    Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Scope of the Report: This report focuses on the Cancer Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, ......
  • Global Hepatocellular Carcinoma Drugs Market Research Report 2018
    Published: 07-Aug-2018        Price: US 2900 Onwards        Pages: 97
    This report studies the global Hepatocellular Carcinoma Drugs market status and forecast, categorizes the global Hepatocellular Carcinoma Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. HCC is the most common form of primary liver cancer in adults and occurs mainly in the patients with underlying liver disease and cirrhosis. The ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs